Halozyme Therapeutics (HALO) Depreciation & Amortization (CF) (2010 - 2026)
Halozyme Therapeutics' Depreciation & Amortization (CF) came in at $4.5 million for Q2 2026, up 66.7% from $2.7 million a year earlier and up 6.6% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Halozyme Therapeutics reported Depreciation & Amortization (CF) of $14.72 million, up 37.7% year-over-year; for FY2025, it came in at $11.4 million, up 10.7% from FY2024.
- Depreciation & Amortization (CF) carries a five-year compound annual growth rate of 28.1% (FY2020 to FY2025).
- Going back by year, Depreciation & Amortization (CF) was $10.3 million in FY2024 (-7.2%), $11.1 million in FY2023 (+70.8%), $6.5 million in FY2022 (+116.7%) and $3 million in FY2021 (-9.1%).
- The Q2 2026 figure represents the highest quarterly Depreciation & Amortization (CF) in data going back to Q3 2010.
- Year-over-year, Depreciation & Amortization (CF) has increased for six consecutive quarters, with growth averaging 19.1% over the last eight quarters.
- The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q4 2022 (growth of 231.1%), and the weakest in Q3 2021 (a decline of 12.5%).
- Business Quant data shows HALO's Depreciation & Amortization (CF) at $4.22 million (Q1 2026), $3.3 million (Q4 2025) and $2.7 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 534.00 Mn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 1.96 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 194.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 599.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.93 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.11 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 98.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 1.62 Bn |
| 10 | Halozyme Therapeutics | 12.53 Bn | 11.13 Bn | 401.83 Mn | 4.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.50 Mn |
| Mar 31, 2026 | 4.22 Mn |
| Dec 31, 2025 | 3.30 Mn |
| Sep 30, 2025 | 2.70 Mn |
| Jun 30, 2025 | 2.70 Mn |
| Mar 31, 2025 | 2.70 Mn |
| Dec 31, 2024 | 2.69 Mn |
| Sep 30, 2024 | 2.60 Mn |
| Jun 30, 2024 | 2.60 Mn |
| Mar 31, 2024 | 2.44 Mn |
| Dec 31, 2023 | 2.90 Mn |
| Sep 30, 2023 | 2.70 Mn |
| Jun 30, 2023 | 2.80 Mn |
| Mar 31, 2023 | 2.62 Mn |
| Dec 31, 2022 | 2.57 Mn |
| Sep 30, 2022 | 2.00 Mn |
| Jun 30, 2022 | 1.10 Mn |
| Mar 31, 2022 | 800,000.00 |
| Dec 31, 2021 | 776,000.00 |
| Sep 30, 2021 | 700,000.00 |
API Access
Halozyme Therapeutics Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();